Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin | Journal of the American Heart Association
Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin: a sequential cohort study | BMJ Open
Anticoagulant Comparison Chart
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
Direct Oral Anticoagulants for Secondary Stroke Prevention - Practical Neurology
Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide | SpringerLink
Current status of oral anticoagulant adherence in Japanese patients with atrial fibrillation: A claims database analysis - Journal of Cardiology
Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study - Clinical Gastroenterology and Hepatology
Switching between anticoagulant regimes; *half dose for edoxaban;... | Download Scientific Diagram
Anticoagulants | Health Navigator NZ
Recommendations for Switching to and From Rivaroxaban 9 | Download Table
JCM | Free Full-Text | Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants | HTML
Oral anticoagulants: Optimizing venous thromboembolism management S. Aleidan FA - J Appl Hematol
Time for a change? Switching anticoagulants in patients with AF or VTE | Thrombosis Adviser
T1.medium.gif
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial - The Lancet Haematology
The market for oral anticoagulants | Nature Reviews Drug Discovery
Switching between anticoagulant regimes; *half dose for edoxaban;... | Download Scientific Diagram
OpenSAFELY: impact of national guidance on switching from warfarin to direct oral anticoagulants (DOACs) in early phase of COVID
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic - Thrombosis Research
Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism – The SWAN Study | PLOS ONE
Direct Oral Anticoagulants for Secondary Stroke Prevention - Practical Neurology
